CD274 and cancer: The TME, also comprising immune cells, significantly influences tumour development as cancer cells evade the immune system via mechanisms including modulation of PD‐L1 expression.[148] Understanding these interactions will improve cancer immunotherapy; and microfluidic platforms are enabling tools for intercellular interaction investigation.